Analyst Reco. Alector, Inc.

Equities

ALEC

US0144421072

Real-time Estimate Cboe BZX Other stock markets 01:05:56 2024-05-20 pm EDT			5-day change	1st Jan Change
5.475 ^USD	+0.64%		+1.11%	-31.70%

May. 14	Transcript : Alector, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:55 AM
May. 08	Alector, Inc. Reiterates Revenue Guidance for the Year Ending 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stifel Upgrades Alector to Buy From Hold, Adjusts Price Target to $15 From $8	Dec. 14	MT
Deutsche Bank Initiates Coverage on Alector With Buy Rating, $12 Price Target	Dec. 12	MT
Mizuho Securities Trims Price Target on Alector to $9 From $10, Keeps Buy Rating	Nov. 16	MT
Cantor Fitzgerald Starts Alector at Overweight With $13 Price Target	23-09-22	MT
Mizuho Cuts Price Target on Alector to $10 From $12, Keeps Buy Rating	23-08-11	MT
Stifel Adjusts Price Target on Alector to $8 From $10, Maintains Hold Rating	23-08-08	MT
Barclays Adjusts Price Target on Alector to $12 From $14, Maintains Overweight Rating	23-05-05	MT
Morgan Stanley Adjusts Price Target on Alector to $10 From $11, Maintains Equal-Weight Rating	23-03-03	MT
BTIG Adjusts Price Target on Alector to $16 From $54, Keeps Buy Rating	23-03-02	MT
Mizuho Adjusts Price Target on Alector to $12 From $15, Keeps Buy Rating	23-03-02	MT
Citigroup Adjusts Price Target on Alector to $12 From $17, Maintains Buy Rating	23-03-01	MT
Morgan Stanley Adjusts Price Target on Alector to $11 From 13, Maintains Equalweight Rating	23-01-24	MT
Citigroup Adjusts Price Target on Alector to $17 From $19, Maintains Buy Rating	22-11-10	MT
Morgan Stanley Downgrades Alector to Equalweight From Overweight, Cuts Price Target to $13 From $27	22-09-09	MT
Citigroup Adjusts Alector's Price Target to $19 From $34, Reiterates Buy Rating	22-07-11	MT
Mizuho Securities Initiates Alector at Buy with $15 Price Target	22-07-07	MT
Mizuho Initiates Alector with Buy Rating, $15 Price Target, Represents 'Classic' Risk/Reward in Biotech	22-07-06	MT
Goldman Sachs Adjusts Alector's Price Target to $6 from $9, Keeps Sell Rating	22-05-24	MT
Barclays Adjusts Alector's Price Target to $14 from $42, Keeps Overweight Rating	22-05-11	MT
Goldman Sachs Initiates Coverage on Alector With Sell Rating, $9 Price Target	22-04-13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Alector, Inc.

Equities

ALEC

US0144421072

Analyst Reco.

Filters